Ovarian cancer is known as the “silent killer” for a reason—it often develops without clear symptoms until it reaches an advanced stage, making early diagnosis a challenge. But a wave of innovation is turning the tide. Cutting-edge tools and tests are helping doctors detect ovarian cancer earlier and more accurately than ever, fueling rapid growth in the Ovarian Cancer...

The global preimplantation genetic testing (PGT) market was valued at approximately USD 802.2 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. Several factors are contributing to this growth, notably the rising prevalence of genetic disorders such as single gene, mitochondrial, and other hereditary conditions. As awareness...

Newborn Screening Industry The global newborn screening market size was valued at USD 789.35 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.54% from 2023 to 2030.The rising neonatal population, increasing cases of congenital diseases in newborns, growing consumer awareness, and favorable initiatives & support from various governments organizing several...

The global newborn screening market size is expected to reach USD 1.40 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.54% from 2023 to 2030. The growth of the market for newborn screening is majorly attributed to favorable reimbursement policies and government support programs, as well as the presence of key...

The global newborn screening market was valued at USD 789.35 million in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 7.54% from 2023 to 2030. Key factors expected to drive this growth include the increasing neonatal population, a rising incidence of congenital diseases in newborns, greater consumer awareness, and supportive initiatives and programs from...

The global pharmaceutical sterility testing market size is anticipated to reach USD 3.28 billion by 2030 and is projected to grow at a CAGR of 11.02% from 2024 to 2030, according to a new report by Grand View Research, Inc. A growing number of drug launches worldwide, and rising government investments are anticipated to influence the global market positively. As pharmaceutical companies...

Preimplantation Genetic Testing Industry The global preimplantation genetic testing market size is expected to reach USD 1.54 billion by 2030, growing at 10.3% CAGR from 2024 to 2030, as per the new report by Grand View Research, Inc. Recent technological advancements in testing have changed the current practice of prenatal screening and early detection of chromosomal...

Preimplantation Genetic Testing Industry The global preimplantation genetic testing market size was estimated at USD 802.2 million in 2023 and is expected to grow at a CAGR of 10.3% from 2024 to 2030. The growing prevalence of single gene, mitochondrial, and other genetic disorders is expected to drive the demand for preimplantation diagnosis and screening processes in the coming years. The...